This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ray, S. Articles by Felsher, D. W. Search for Related Content PubMed PubMed Citation Articles by Ray, S. Articles by Felsher, D. W.

MYC Can Induce DNA Breaks In vivo and In vitro Independent of Reactive Oxygen Species

¹ Division of Oncology, Departments of Medicine and Pathology, ² Genetics, and ³ Dermatology, Stanford University School of Medicine, Stanford, California

Requests for reprints: Dean W. Felsher, Department of Medicine, Division of Oncology, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA 94305. Phone: 650-498-5269; Fax: 650-725-1420; E-mail: dfelsher{at}stanford.edu.

MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis. Here we show that MYC can induce DNA breaks both in vitro and in vivo independent of increased production of reactive oxygen species (ROS). We provide an insight into the specific circumstances under which MYC generates ROS in vitro and propose a possible mechanism. We found that MYC induces DNA double-strand breaks (DSBs) independent of ROS production in murine lymphocytes in vivo as well as in normal human foreskin fibroblasts (NHFs) in vitro in normal (10%) serum, as measured by H2AX staining. However, NHFs cultured in vitro in low serum (0.05%) and/or ambient oxygen saturation resulted in ROS-associated oxidative damage and DNA single-strand breaks (SSBs), as measured by Ape-1 staining. In NHFs cultured in low versus normal serum, MYC induced increased expression of CYP2C9, a gene product well known to be associated with ROS production. Specific inhibition of CYP2C9 by small interfering RNA was shown to partially inhibit MYC-induced ROS production. Hence, MYC overexpression can induce ROS and SSBs under some conditions, but generally induces widespread DSBs in vivo and in vitro independent of ROS production. (Cancer Res 2006; 66(13): 6598-605)

This article has been cited by other articles:

				J. A. Graves, M. Metukuri, D. Scott, K. Rothermund, and E. V. Prochownik Regulation of Reactive Oxygen Species Homeostasis by Peroxiredoxins and c-Myc J. Biol. Chem., March 6, 2009; 284(10): 6520 - 6529. [Abstract] [Full Text] [PDF]

				D. W. Felsher, I. B. Weinstein, and A. Joe Oncogene Addiction versus Oncogene Amnesia: Perhaps More than Just a Bad Habit? Cancer Res., May 1, 2008; 68(9): 3081 - 3086. [Abstract] [Full Text] [PDF]

				A. M. Unni, T. Bondar, and R. Medzhitov Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance PNAS, February 5, 2008; 105(5): 1686 - 1691. [Abstract] [Full Text] [PDF]

				M. Reimann, C. Loddenkemper, C. Rudolph, I. Schildhauer, B. Teichmann, H. Stein, B. Schlegelberger, B. Dorken, and C. A. Schmitt The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo Blood, October 15, 2007; 110(8): 2996 - 3004. [Abstract] [Full Text] [PDF]

				K. H. Maclean, M. B. Kastan, and J. L. Cleveland Atm Deficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis Mol. Cancer Res., July 1, 2007; 5(7): 705 - 711. [Abstract] [Full Text] [PDF]